RK
Ravi Kishore Mehta
About Ravi Kishore Mehta
Data last updated:
Ravi Kishore Mehta is a Director at Ravi Pharma Trade Private Limited (since 2016). The companies operate in Trading. Ravi Pharma Trade Private Limited reported revenue of ₹31.3 Lakh (FY 2024). Earlier, Ravi Kishore Mehta was a Director at Digintelligence Private Limited (from 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Apr 2016 | 2016 | ₹31.3 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Jul 2021 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ravi Kishore Mehta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Akansha Mehta | 08053401 | Ravi Pharma Trade Private Limited | Director |
| Trishla Mehta | 07476195 | Ravi Pharma Trade Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Kishore Mehta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Kishore Mehta
Ravi Kishore Mehta currently holds 1 directorship: Ravi Pharma Trade Private Limited (Director, since 28 Apr 2016, revenue ₹31.3 Lakh (FY 2024)).
Ravi Kishore Mehta was first appointed on 28 Apr 2016 as Director at Ravi Pharma Trade Private Limited. The most recent appointment on record is 30 Jul 2021 at Digintelligence Private Limited.
Ravi Kishore Mehta held 1 earlier board appointment: Digintelligence Private Limited (Director, from 30 Jul 2021).
The current boards of Ravi Kishore Mehta's companies include Akansha Mehta (Ravi Pharma Trade Private Limited), Trishla Mehta (Ravi Pharma Trade Private Limited).